Cowen Inc’s Ascendis Pharma A/S ASND Stock Holding History

Cowen Inc’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,150	Closed	-$606K	–	455
2019 Q1	$606K	Buy	+5,150	New	+$451K	0.07%	145

Other funds holding ASND

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Cowen Inc's ASND Position: Q2 2019 in Review

Cowen Inc sold out of Ascendis Pharma A/S (ASND) in Q2 2019, closing a stake of 5,150 shares — an estimated $606K sold.

Cowen Inc first reported a position in ASND in Q1 2019 and held it in 1 quarter. The position peaked at $606K in Q1 2019. 132 funds tracked by Wall St. Rank hold ASND as of Q2 2019.

Cowen Inc reported no remaining Ascendis Pharma A/S position as of Q2 2019 after selling out during the quarter.
Cowen Inc sold 5,150 Ascendis Pharma A/S shares in Q2 2019, an estimated $606K.
Cowen Inc first reported a position in Ascendis Pharma A/S in Q1 2019 and held it in 1 quarter.
Cowen Inc's Ascendis Pharma A/S position peaked at $606K in Q1 2019.
132 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.